DIANE DECAROLIS: Open Payments
NPI 1285884890 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 19 payments from 7 companies in 2025. Trend: 2023 $806 · 2024 $797 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $384 |
| ABBVIE INC. | 6 | $268 |
| Alkermes, Inc. | 5 | $197 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, Auvelity, REXULTI, COBENFY, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
